Artielle ImmunoTherapeutics, Inc. Announces Positive Results of Phase 1 Multiple Sclerosis Trial Results Presented at 13th Congress of the European Federation of Neurological Societies in Florence, Italy
9/14/2009 9:50:16 AM
More...
|
Virogenomics, Inc. Spin-off, Artielle ImmunoTherapeutics, Inc., Secures $11 Million Equity Financing
10/19/2005 5:08:52 PM
More...
|